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Activation of extracellular signal-regulated protein
kinase 5 is essential for cystitis- and nerve growth
factor-induced calcitonin gene-related peptide
expression in sensory neurons
Sharon J Yu, Chun-mei Xia, Jarren C Kay and Li-Ya Qiao*
Abstract
Background: Cystitis causes considerable neuronal plasticity in the primary afferent pathways. The molecular
mechanism and signal transduction underlying cross talk between the inflamed urinary bladder and sensory
sensitization has not been investigated.
Results: In a rat cystitis model induced by cyclophosphamide (CYP) for 48 h, the mRNA and protein levels of the
excitatory neurotransmitter calcitonin gene-related peptide (CGRP) are increased in the L6 dorsal root ganglia (DRG)
in response to bladder inflammation. Cystitis-induced CGRP expression in L6 DRG is triggered by endogenous nerve
growth factor (NGF) because neutralization of NGF with a specific NGF antibody reverses CGRP up-regulation
during cystitis. CGRP expression in the L6 DRG neurons is also enhanced by retrograde NGF signaling when NGF is
applied to the nerve terminals of the ganglion-nerve two-compartmented preparation. Characterization of the
signaling pathways in cystitis- or NGF-induced CGRP expression reveals that the activation (phosphorylation) of
extracellular signal-regulated protein kinase (ERK)5 but not Akt is involved. In L6 DRG during cystitis, CGRP is
co-localized with phospho-ERK5 but not phospho-Akt. NGF-evoked CGRP up-regulation is also blocked by inhibition
of the MEK/ERK pathway with specific MEK inhibitors U0126 and PD98059, but not by inhibition of the PI3K/Akt
pathway with inhibitor LY294002. Further examination shows that cystitis-induced cAMP-responsive element
binding protein (CREB) activity is expressed in CGRP bladder afferent neurons and is co-localized with
phospho-ERK5 but not phospho-Akt. Blockade of NGF action in vivo reduces the number of DRG neurons
co-expressing CGRP and phospho-CREB, and reverses cystitis-induced increases in micturition frequency.
Conclusions: A specific pathway involving NGF-ERK5-CREB axis plays an essential role in cystitis-induced sensory
activation.
Keywords: ERK5, Akt, NGF, CGRP, DRG
Introduction
Cystitis induces considerable changes in the primary af-
ferent pathways that play a significant role in bladder
hyperactivity. The molecular mechanism and signal
transduction that mediate the cross talk between the
inflamed urinary bladder and sensory sensitization has
not been investigated. The neuropeptide calcitonin gene-
related peptide (CGRP) is enriched in the primary
afferent neurons in the dorsal root ganglia (DRG) and is
one of the most important nociceptive markers in the
control of pain and inflammation [1-10]. Mice lacking
CGRP or receiving pharmacological inhibition of CGRP
activity do not develop hyperalgesia or central neuro-
pathic pain after inflammation [4-10]. Conversely, mice
receiving intrathecal CGRP peptide exhibit nociceptive
behavior [11-13]. The involvement of CGRP in nocicep-
tive transmission following noxious stimulation of the per-
ipheral/visceral organ/tissue includes its up-regulation in
the DRG [3,5,14-21] and its release centrally to the dorsal
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horn of the spinal cord [11,16,22,23]. This is also particu-
larly true with cystitis that a previous study by Vizzard
[21] shows that chronic irritation of the urinary bladder
following multi-dose cyclophosphamide (CYP) treatment
causes a CGRP increase in bladder afferent neurons. Thus
investigation of the endogenous molecular pathways by
which CGRP is regulated in sensory neurons during cyst-
itis will provide insights into the mechanisms underlying
visceral inflammation and pain.
In adult rat DRG, about half of the primary sensory
populations are peptidergic that are marked by CGRP
[24,25]. These cells express the active form of TrkA [26]
thus they are able to respond to nerve growth factor
(NGF). The action of NGF on CGRP expression in sen-
sory neurons is demonstrated in several forms. In DRG
neuronal mass culture, application of NGF increases
CGRP transcription [27] in a ras- dependent manner [28].
In animals, intrathecal infusion of NGF can counteract the
decrease of CGRP mRNA caused by sciatic nerve transec-
tion [29]. In an analogous manner, treatment with NGF
antiserum reduces the endogenous level of CGRP in sen-
sory neurons [30] and also prevents the increase in CGRP
content in the sciatic nerve of the inflamed paw [31]. In
addition to the local action of NGF on CGRP expression,
NGF is able to facilitate a retrograde signal by which NGF
applied to the extremity of capsaicin-treated rats can
counteract capsaicin-induced reduction in CGRP mRNA
level in the DRG [32]. These in vitro and in vivo studies
suggest a close interrelationship between NGF and CGRP
in sensory neurons; however, the detailed signaling trans-
duction pathways that mediate NGF-induced CGRP ex-
pression in sensory neurons in animals with disease have
yet to be determined.
Three major signaling pathways are activated by NGF
binding to TrkA in neurons: the extracellular signal-
regulated protein kinase (ERK) pathway, the phosphati-
dylinositol 3-kinase (PI3K)/Akt pathway, and the
phospholipase C (PLC)γ pathway [33]. Activation of
ERK (i.e. ERK1/2, ERK5) or PI3K/Akt pathway enhances
gene expression through the activation of transcription
factor CREB, the cAMP-responsive element binding pro-
tein [33-35]. Activation of the PLCγ pathway leads to
Ca2+ and Na+ influx through the activation of ion chan-
nels, Ca2+ release from stores, and further leads to CREB
activation [36]. Considering that the CGRP promoter
contains a cAMP-responsive element and CGRP expres-
sion is regulated by CRE-mediated transcription [37-39],
it is likely that one or more of these pathways can be
involved in NGF-induced CGRP expression. A recent
study shows that inhibition of mitogen activated protein
kinase kinase (MAPKK, MEK) activity blocks the ability
of NGF to increase CGRP expression in cultured DRG
neurons [28,]. The interplay of the PI3K/Akt pathway in
NGF-induced MAPK activation has also been discussed
(see review: [40]). In regard to the unique feature of
NGF retrograde signaling, activation of MEK/ERK and
PI3K/Akt are involved in a region-dependent, isoform-
specific manner [41-43]. In sensory neurons, ERK5 ra-
ther than ERK1/2 is activated to mediate a retrograde
survival response to NGF [34].
Several animal models have demonstrated an elevation
of NGF in the inflamed peripheral organs/tissues includ-
ing hind paw [44], the urinary bladder [45,46], and the
distal colon [47]. This target-derived NGF can influence
sensory activity via retrograde transport [47]. Previous
studies by us [48,49] and others [50] have demonstrated
that during cystitis the ERK5 and CREB are activated in
bladder afferent neurons and intrathecal application of
PD98059, an inhibitor that prevents both ERK1/2 and
ERK5 activities [51], significantly decreases micturition
frequency in inflamed animals but has no effect on blad-
der reflex contractions of non-inflamed bladder. Along
with this line of research, the present study examines
1) whether endogenous NGF has a role in CGRP expres-
sion in the DRG and in inducing bladder overactivity
caused by cystitis; 2) whether cystitis-induced CGRP
involves NGF retrograde signaling that involves activa-
tion of ERK5 and Akt; and 3) the involvement of CREB
in NGF signaling. Our results suggest a unique pathway
involving ERK5-CREB but not Akt in CGRP up-
regulation in the DRG during cystitis.
Materials and methods
Experimental animals and reagents
Adult male rats (150–200 g) from Harlan Sprague
Dawley, Inc. (Indianapolis, IN) were used. All experi-
mental protocols involving animal use were approved by
the Institutional Animal Care and Use Committee at the
Virginia Commonwealth University (IACUC # AM10315).
Animal care was in accordance with the Association for As-
sessment and Accreditation of Laboratory Animal Care
(AAALAC) and National Institutes of Health guidelines.
All efforts were made to minimize the potential for animal
pain, stress or distress as well as to reduce the number of
animals used. CYP and other chemicals used in this experi-
ment were purchased from Sigma-Aldrich (St. Louis, MO).
Cyclophosphamide-induced cystitis
CYP cystitis was induced in rats by the technique previ-
ously described [52]. Briefly, cystitis was induced in rats
by injecting CYP intraperitoneally at a single dose of
150 mg/kg for 48 hours (h). Control rats received
volume-matched injections of saline. All injections were
performed under isoflurane (2%) anesthesia.
Anti-NGF and control IgG treatment
A NGF antibody or control IgG (Santa Cruz Biotechnol-
ogy, Inc. Santa Cruz, CA) was injected intraperitoneally at
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a dose of 30 μg/kg body weight according to previously
published protocol [52]. A single dose of NGF antibody or
control IgG was made immediately after the CYP injec-
tion. This treatment regimen effectively blocked the action
of NGF in the inflamed urinary bladder [52].
Retrograde labeling
Under anesthesia (2.5% isoflurane, SurgiVet, Smiths Med-
ical PM, Inc. Waukesha, WI), the rat urinary bladder was
exposed under a sterile environment with a lower abdom-
inal incision. Neuronal tracing agent Fast Blue (FB, 4%,
weight/volume; Polysciences, Inc. Warrington, PA) was
injected into 8 sites (5 μL per site) in the bladder wall for
retrograde labeling of bladder afferent neurons in the
DRG. To prevent leakage and labeling of adjacent tissues,
the needle was left in place for 30 sec after each injection
and a cotton swab was held close to the injection site to
wipe off any excess dye that might leak from the needle
tip during the needle withdrawal. In this manner, no vis-
ible leakage of the dyes was observed after each injection.
Injections into the lumen, major blood vessels, or overly-
ing fascial layers were avoided. The incision was closed
with 4–0 sutures. The rats were allowed for survival until
the harvest of the tissues.
Tissue harvesting
For immunohistochemistry, animals were deeply
anesthetized with isoflurane (2–3%) and then underwent
euthanasia via intracardiac perfusion with oxygenated
Krebs buffer (pH 7.4; 95% O2, 5% CO2) followed by 4%
paraformaldehyde. The L6 DRGs were identified and
sectioned parasagitally at a thickness of 20 μm. For
ganglion-nerve preparation, animals were sacrificed with
overdose of isoflurane followed by thoracotomy. The L6
DRG along with the distal spinal nerve were freshly dis-
sected out and placed into Dulbecco's Modified Eagle
Medium (DMEM) with or without inhibitors for culture.
For real-time PCR, the L6 DRG was freshly dissected
out and subjected to RNA extraction.
Immunohistochemistry
An on-slide technique was used for immunostaining of
the DRG sections. DRG sections were incubated with
blocking solution containing 3% normal donkey serum
(Jackson ImmunoResearch, West Grove, PA) in PBST
(0.3% Triton X-100 in 0.1 M PBS, pH 7.4) for 30 min,
followed by specific primary antibodies overnight at 4°C.
These antibodies included mouse anti-CGRP (1:2000,
Abcam, Cambridge, MA), rabbit anti-CGRP (1:1000,
Millipore, Lake Placid, NY), rabbit anti-phospho-ERK5
(1:400, Cell Signaling Technology, Inc. Danvers, MA),
goat anti-phospho-ERK5 (1:200, Santa Cruz Biotechnol-
ogy, Inc. Santa Cruz, CA), rabbit anti-phospho-Akt
(1;500, Cell Signaling Technology, Inc. Danvers, MA),
mouse anti-phospho-Akt (1:2000, Cell Signaling Tech-
nology, Inc. Danvers, MA), and rabbit anti-phospho
(p)-CREB (1:1000, Cell Signaling Technology, Inc.
Danvers, MA). After rinsing (3 × 10 min with 0.1 M
PBS), tissues were incubated with fluorescence-
conjugated species-specific secondary antibody Alexa
594 or 488 (1:500, Molecular Probes, Eugene, OR) for
2 h at room temperature. Following washing, the slides
were coverslipped with Citifluor (Citifluor Ltd., London).
DRG cells with visible nucleus were counted with a
Zeiss fluorescent photomicroscope. CGRP and p-CREB
cell profiles were counted in 6 to 10 sections randomly
chosen from each L6 DRG. The area of section containing
cells (excluding the area containing fibers) was selected
using free-line tools integrated with the AxioVision meas-
urement software (Carl Zeiss, Inc.) and was measured as
mm2. The number of positively stained cells was normal-
ized against the measured area and expressed as number
cells per mm2. To avoid double counting, we have chosen
every third section for one specific antibody stained.
RNA extraction and quantitative real-time PCR
Total RNA was extracted using a RNA extraction kit
RNAqueous (Ambion, TX). RNA concentration was deter-
mined spectrophotometrically. cDNA was synthesized
using Cloned AMV First-Strand Synthesis Kit (Invitrogen
Life Technologies, Grand Island, NY) with random hexam-
ers. Following reverse transcription, quantitative real-time
PCR was performed for CGRP with Taqman probes mixed
with PCR Master-Mix for 40 cycles (95°C for 15 sec, 60°C
for 1 min) on a 7300 real-time PCR system (Applied Bio-
systems, Foster City, CA). Quantitative real-time PCR of
the same sample was performed for β-actin expression as
internal control. The levels of CGRP mRNA were normal-
ized against β-actin expression in the same sample that
was calculated with ΔCt method. The expression levels of
the target gene in control animal from each independent
experiment was considered as 1, and the relative expres-
sion level of these genes in experimental animals was
adjusted as a ratio to its control in each independent ex-
periment and expressed as fold changes (2-ΔΔCt-fold).
Examination of voiding behavior
Adapted from a published method for mouse [53], void-
ing behavior of the rat was analyzed via a non-invasive
procedure in which the urine was collected naturally
onto an underneath filter paper placed 20 cm below a
meshed cage containing the tested animal. We used a
cage with a dimension of 25 × 15 × 15 cm3 (L ×W×H).
The number of urine drops from each animal in a 2-h
window was counted. Animals treated with CYP
excreted more times (i.e., higher number of urine drops)
with less volume per drop (i.e., smaller urine spots).
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Statistical analysis
Comparison between control and experimental group
was made by using Student's t-test. Results were pre-
sented as mean ± S.E.M. Differences between means at a
level of p ≤ 0.05 were considered to be significant.
Results
Cystitis-induced CGRP mRNA and protein levels in the L6
DRG was blocked by inhibition of NGF action in vivo
Previous studies have demonstrated that chronic cystitis
following multi-dose ten-day treatment with CYP
resulted in a significant increase in CGRP immunoreac-
tivity in bladder afferent neurons located in the L6-S1
DRGs [21]. The present study showed that CGRP produc-
tion was also increased in L6 DRG at 48 h post cystitis in-
duction (Figure 1). Consistently, CGRP immunoreactivity
was expressed in small diameter nociceptive neurons
(Figure 1A-B). The number of CGRP immunoreactive
neurons was significantly increased (p< 0.05) in L6 DRG
at 48 h following CYP treatment (Figure 1C). Real-time
PCR results showed that CGRP transcript was also ele-
vated in L6 DRG during cystitis (Figure. 1D), suggesting
that CGRP was generated by these DRG neurons upon in-
flammatory irritation of the urinary bladder.
It has been well established that NGF serves as an en-
dogenous mediator in some persistent pain states. The
CGRP positive peptidergic sensory neurons often ex-
press TrkA [26], thus are able to respond to NGF action.
To examine whether CGRP up-regulation in the L6
DRG was mediated by endogenous NGF during cystitis,
we administered a NGF neutralizing antibody to rats
with cystitis to block NGF activity in vivo. Cystitic ani-
mals receiving the same amount of control IgG served
as comparison. After 48 h post drug treatment, we
examined the mRNA and protein levels of CGRP in the
L6 DRG (Figure 2). In animals treated with CYP and
control IgG, there was an average of 126.6 ± 10.1 CGRP
cells per mm2 DRG neuronal area (Figure 2A, C). Treat-
ment with NGF neutralizing antibody reduced the num-
ber of DRG neurons expressing CGRP to 30.2 ± 2.7 per
mm2 DRG neuronal area (p< 0.05, Figure 2B, C). Treat-
ment with NGF neutralizing antibody also decreased the
CGRP mRNA level in CYP-treated animals when com-
pared to CYP+ IgG treatment (Figure 2D), suggesting
that endogenous NGF triggered CGRP transcription in
the L6 DRG during cystitis.
CGRP was co-localized with phospho-ERK5 but not
phospho-Akt in L6 DRG during cystitis
We have reported that the level of phospho-ERK5 was
increased in the DRG during cystitis [48]. ERK5 was also
a key molecule activated in the sensory neuronal somata
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Figure 1 Cystitis increased CGRP mRNA and protein levels in L6 DRG. After CYP treatment for 48 h, the CGRP expression was examined in
L6 DRG by immunohistochemistry (A-C) and real-time PCR (D). CGRP was largely expressed in small diameter sensory neurons (A, B). The average
number of DRG neurons per unit area expressing CGRP was significantly increased post CYP treatment (C). The relative level of CGRP mRNA was
also increased in L6 DRG during cystitis (D). Bar = 80 μm. *, p< 0.05 vs control. n = 5-6 animals for each group.
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upon NGF retrograde stimulation of cultured DRG neu-
rons [34]. In the present study, double immunostaining
of the L6 DRG from animals with cystitis showed that a
subpopulation of CGRP cells (Figure 3A, yellow arrows)
also expressed phospho-ERK5 (Figure 3B). In contrast,
CGRP cells did not express phospho-Akt (Figure 3D-F)
even though Akt was also a major downstream inter-
mediate signaling molecule regulated by NGF [33].
These results suggested that activation of ERK5 rather
than Akt was likely responsible for CGRP expression in
the DRG.
Prevention of ERK5 but not Akt activity blocked
retrograde NGF-induced CGRP expression in the DRG
somata
Since phospho-ERK5 was co-localized with CGRP in the
L6 DRG during cystitis (Figure 3A-C), we then examined
whether NGF-induced CGRP in the DRG was mediated
by the ERK5 pathway. We utilized a two-compartmented
L6 DRG-nerve preparation and examined the effect of
retrograde NGF on CGRP expression in the DRG. This
system was chosen based on that NGF was elevated in the
inflamed urinary bladder [45,46] and its retrograde signal
had a critical role in mediating the target tissue-neuron
interaction. Our results showed that application of ex-
ogenous NGF (50 ng/mL) to the nerve terminals caused a
two-fold increase (p< 0.05) in the number of DRG
neurons expressing CGRP in the DRG after 12 h of NGF
treatment (Compare Figure 4B to 4A, Figure 4E). When
we blocked the ERK5 activity with a specific MEK inhibi-
tor U0126 (2 μM) or PD98059 (5 μM), we found that
NGF-induced CGRP expression was reduced by these in-
hibition (Figure 4F, G). In contrast, inhibition of Akt activ-
ity with a PI3K inhibitor LY294002 (5 μM) had no effect
on NGF-induced CGRP expression in the DRG neurons
(Figure 4H). These results suggested that activation of
ERK5 but not Akt mediated retrograde NGF-induced
CGRP expression in the L6 DRG.
CGRP cells co-expressed CREB activity during cystitis
The transcription factor CREB was implicated to func-
tion as a molecular switch underlying neural plasticity
[54]. In cultured sensory neurons, activation of CREB
was involved in retrograde NGF-induced sensory neur-
onal survival response [34]. During cystitis, CREB was
also activated in bladder afferent neurons in the L6 DRG
[49]. It has been reported that in DRG neuronal culture
activation of CREB was a necessary element in NGF-
induced CGRP up-regulation [55]. In the present study,
we found that during cystitis about 75% CGRP cells
(Figure 5A) expressed phospho-CREB (Figure 5B) in the
L6 DRG (Figure 5A-C, yellow arrows); CGRP and
phospho-CREB were also co-expressed in bladder affer-
ent neurons in the L6 DRG (Figure 5D-G, yellow
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Figure 2 NGF immuno-neutralization attenuated cystitis-induced CGRP expression in L6 DRG. The number of CGRP immunoreactive
neurons was significantly higher in L6 DRG from animals treated with CYP and control IgG (A, C) when compared to those from animals treated
with NGF neutralizing antibody and CYP (B, C). Blockade of NGF activity in cystitis animals also reduced CGRP transcription in the L6 DRG (D). *,
p< 0.05 vs CYP+ IgG. n = 5 animals for each group. Bar = 60 μm.
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arrows). It was noteworthy that some of the CGRP neu-
rons did not express phospho-CREB (Figure 5, white
arrows). It could be that these CGRP were not caused by
cystitis, or CREB in these neurons was deactivated
(dephosphorylated) prior to examination. Co-localization
studies also showed that phospho-CREB (Figure 6A, D)
was co-localized with phospho-ERK5 (Figure 6A-C) but
not phospho-Akt (Figure 6D-E) in the L6 DRG during
cystitis.
Blockade of NGF action in vivo reduced cystitis-induced
CREB activation in CGRP neurons and reversed bladder
hyperactivity
To examine whether NGF induced CREB activation
in vivo, we compared the level of phospho-CREB in L6
DRG and in CGRP-expressing neurons in CYP-treated
animals receiving either control IgG or anti-NGF treat-
ment. A significant reduction of phospho-CREB was
found in L6 DRG in animals treated with anti-NGF
(Figure 7B) when compared to control IgG treatment
(Figure 7A, C). Cystitis-caused increases in the number
of L6 DRG neurons co-expressing CGRP and phospho-
CREB were also attenuated by anti-NGF treatment
(Figure 7D). Associated with sensory neuronal activation,
cystitis significantly increased micturition frequency
examined by number of voiding in a 2-h window of
recording from unrestraint non-operated conscious ani-
mals (Figure 7E), suggesting that these animals exhibited
overactive bladder. Anti-NGF treatment reversed
cystitis-induced bladder overactivity (Figure 7E).
Discussion
The key findings of the present study are that activation
of the ERK5 but not the Akt pathway is involved in
cystitis- and retrograde NGF-induced CGRP expression
in primary sensory neurons. A line of evidence shows
that the neuropeptides NGF and CGRP have prominent
roles in nociceptive transmission and inflammatory pain
[1-4,44,56,57]. Viral gene transfer of NGF to the urinary
bladder triggers bladder overactivity [57] suggesting the
ability of viscerally expressed NGF in regulating sensory
activity. However, the molecular pathways by which vis-
ceral NGF induces bladder sensory activity is not investi-
gated. In the present study, we combine in vivo and
in vitro approaches and demonstrate that NGF regulates
sensory activity by activating CREB and CGRP in pri-
mary sensory neurons in the DRG, which is mediated by
a unique signaling pathway involving activation of ERK5.
Following inflammatory irritation of the urinary bladder
in animals or patients, the level of NGF is elevated in
the viscera [45,46,58,59]. NGF binding to its receptor
TrkA may undergo retrograde transport to the DRG
where they regulate sensory activity by increasing the
ERK5 and CREB activities as well as CGRP production.
ERK5 is a novel member of the ERK family that is
sensitive to cytokine, stress and mitogenic factors. The
present study shows that activation of ERK5 (phospho-
ERK5) in the L6 DRG during cystitis is associated with
CGRP expression and CREB activation. Prevention of
ERK activity with a MEK inhibitor PD98059 that
blocks both ERK1/2 and ERK5 attenuates retrograde
CGRP pAkt CGRP+pAkt
D F
CGRP  pERK5 CGRP+pERK5
A B C
E
Figure 3 Co-localization of CGRP with phospho-ERK5 but not phospho-Akt in L6 DRG during cystitis. Double immunostaining showed
that a subpopulation of CGRP cells (A, green cells indicated by yellow arrows) also expressed phospho-ERK5 (B, red nuclear staining). In contrast,
CGRP cells did not express phospho-Akt (D-F, blue arrows indicated CGRP cells, white arrows indicated Akt cells).
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NGF-induced CGRP up-regulation in the DRG neuronal
soma. These findings are consistent to published studies
in showing that activation of ERK5 is a key pathway in
retrograde NGF-induced sensory neuronal survival re-
sponse [34]. Several studies have also demonstrated that
NGF-induced sensitization of the TRPV1 response is atte-
nuated by inhibition of the PI3K/Akt pathway when NGF
is applied directly to the neurons [60,61] or injected intra-
dermally [62] suggesting that the PI3K/Akt participates in
both local and retrograde NGF action. In our study, pre-
vention of the PI3K/Akt activity fails to block retrograde
NGF-induced CGRP expression in the DRG. During cyst-
itis, the phospho-Akt is not co-expressed with either
CGRP or phospho-CREB suggesting that the PI3K/Akt
pathway is unlikely serving upstream of the pathway lead-
ing to CGRP expression and CREB activation in these
neurons. Immuno-colocalization study shows that 60% of
CGRP DRG neurons contain TRPV1 immunoreactivity
[63]; however, there is scarce overlap of TRPV1 and CGRP
fibers in the dorsal horn of the spinal cord [63]. These
results suggest that PI3K/Akt-mediated TRPV1 and MEK/
ERK5-mediated CGRP may have distinct function in me-
diating sensory activity (Figure 8).
Cystitis is accompanied with increased urinary urgency,
frequency and suprapubic and pelvic pain. Emerging evi-
dence show that inflammatory mediators generated in the
urinary bladder triggers bladder sensory activation thereby
contributing to bladder hyperactivity [64]. Following CYP
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Figure 4 Retrograde NGF-induced CGRP expression was mediated by the MEK/ERK pathway but not by the PI3K/Akt pathway. In
two-compartmented culture, the gangalia was pre-treated with vehicle (vehicle, A, B, E), or one of the inhibitors against the MEK/ERK pathway
(C, F: U0126; G: PD98059), or the PI3K/Akt pathway (D, H: LY294002) followed by NGF treatment of the nerve terminals (B, C, D). After 12 h of
NGF treatment, the level of CGRP was increased in the sensory neuronal cell bodies by 2 fold when compared to control (E). Both U0126 (F) and
PD98059 (G: PD) pre-treatment blocked the retrograde NGF-facilitated CGRP expression in DRG. LY294002 (LY) pre-treatment did not affect the
level of CGRP in the ganglia induced by retrograde NGF (H). Bar = 120 μm. *, p< 0.05 vs vehicle. Results were from 4 independent experiments
for each treatment.
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treatment, a number of inflammatory mediators are pro-
duced and released into the lamina propria where they
sensitize the sensory nerve terminals and cause sensory
hypersensitivity. The present study along with previous
publications demonstrates that NGF is a critical endogen-
ous mediator in cystitis-induced bladder sensory
FB  CGRP p-CREB merge
CGRP p-CREB CGRP/p-CREB
A  B C
D E  F G
Figure 5 Co-localization of CGRP with phospho-CREB in bladder afferent neurons during cystitis. Double immunostaining showed that
CGRP cells (A, green cells indicated by yellow arrows) often expressed phospho (p)-CREB (B, red nuclear staining, C was the merged
photomicrograph of A and B indicating co-localization of CGRP and p-CREB: yellow arrows) during cystitis. In FB-labeled bladder afferent neurons
(D, blue cells indicated by yellow arrows), CGRP (E, green cells) was also co-expressed with p-CREB (F: red nuclear staining; G was the merged
photomicrograph of D, E and F indicating bladder afferent neurons expressing both CGRP and p-CREB indicated by yellow arrows). White arrows
indicated CGRP neurons that did not have p-CREB. Bar = 60 μm.
pCREB pAkt  pAkt+pCREB
D F
pCREB  pERK5 pERK5+pCREB
A B  C
E
Figure 6 Co-localization of phospho-CREB with phospho-ERK5 but not phospho-Akt in L6 DRG during cystitis. Double immunostaining
showed that phospho-CREB in L6 DRG during cystitis (A, D: red nuclear staining) was co-localized with phospho-ERK5 (B, C: green nuclear
staining) but not phospho-Akt (E, F: green cells). Bar = 60 μm.
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hyperactivity [65]. Blockade of NGF action in vivo not
only attenuates cystitis-induced CREB activation and
CGRP expression in the DRG but also reverses cystitis-
induced increases in micturition frequency. NGF gener-
ated in the urinary bladder [45,46] may undergo retro-
grade transport to regulate gene expression in the DRG.
Our study shows that application of NGF to the sensory
nerve terminals indeed increases CGRP expression in the
DRG neuronal soma. The retrograde NGF action on
affecting bladder sensory activity has also been demon-
strated by injection of exogenous NGF into the normal rat
bladder which results in bladder hyperactivity [57]. The
present study provides a molecular basis for the physio-
logical role of NGF in regulating bladder activity which is
that NGF in the urinary bladder sensitizes bladder afferent
neurons by regulating CRE-mediated gene expression
such as CGRP.
The interplay between NGF and CGRP pathways has
long been suggested. Injection of NGF (alphaNGF) anti-
serum to nonoperated animals decreases the levels of
CGRP protein expressed in DRG [30]. CGRP mRNA in
DRG was also absent from TrkA−/− mice as well as in
NGF-deprived DRG explants [66]. In the present study,
we demonstrate that injection of NGF antibody reverses
both the elevated levels of CGRP mRNA and protein in
L6 DRG induced by cystitis. The promoter region of the
CGRP gene contains a consensus sequence responsive to
the transcription factor CREB [37]. In L6 DRG during
cystitis, a large population of CGRP neurons contains
phospho-CREB. This suggests that CREB may also be
involved in NGF signaling during cystitis. It has been
reported that retrograde NGF regulates CREB activation
in cultured rat sympathetic neurons, and plays a critical
role in neuronal plasticity [54]. Consistent with this no-
tion, our results show that in cystitis endogenous NGF
facilitates CREB activation in primary sensory neurons
because NGF antibody treatment blocks cystitis-induced
CREB activation in L6 DRG. There are also parallel
decreases in the CGRP expression along with CREB acti-
vation in DRG neurons co-expressing both molecules
following NGF antibody treatment of the cystitis ani-
mals. Taken together, these results suggest that NGF
regulates sensory activity and CGRP expression involves
CREB activation during cystitis. CREB can be activated
by a number of kinases including the Ca2+/CaM-
dependent kinase II, PKA, and MAPK and Akt [67], and
occupies approximately 4,000 promoter sites in human
tissues [68]. Thus, in addition to CGRP, other neuropep-
tides and ion channels may also be regulated by CREB
in sensory neurons (Figure 8). This is shown consistently
in our studies that in the L6 DRG during cystitis many
phospho-CREB neurons do not express CGRP.
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Figure 7 NGF immuno-neutralization reduced the level of CREB phosphorylation in CGRP neurons during cystitis and reversed
cystitis-induced bladder overactivity. The number of phospho (p)-CREB immunoreactive neurons was significantly higher in L6 DRG from
animals treated with CYP and control IgG (A, C) when compared to those from animals treated with NGF neutralizing antibody and CYP (B, C).
NGF neutralization also reduced cystitis-induced increases in the number of L6 DRG neurons co-expressing CGRP and p-CREB (D), and reversed
cystitis-induced increases in micturition frequency (E). *, p< 0.05 vs CYP+ IgG. #, p< 0.05 vs vehicle treatment. n = 4 animals for each group.
Bar = 40 μm.
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Examination of retrograde pathways that are initiated
by NGF leading to CGRP expression in DRG shows that
application of specific inhibitors against the MEK/ERK
pathway blocks retrograde NGF-induced CGRP up-
regulation in the sensory neuronal cell body, while in-
hibition of the PI3K/Akt pathway has no effect. Up-
regulation of CGRP by the ERK MAPK pathway has also
been demonstrated in trigeminal ganglia neurons [69]. It
is noteworthy that the current study does not preclude
the possibility of other factors in regulating CGRP ex-
pression in the DRG. These factors include but are not
limited to growth factors, cytokines, purinergic system,
and glutamate and receptors that are also elevated in the
inflamed bladder and/or sensory pathways during cystitis
[64]. Cytokine activin is able to increase CGRP expres-
sion in sensory neurons in culture and in vivo after per-
ipheral inflammation [70,71]. It is shown that activin
acts synergistically with NGF in inducing CGRP expres-
sion in sensory neurons [72].
In conclusion, the present study demonstrates that ac-
tivation of a unique signaling involving activation of
ERK5 but not Akt in cystitis- and NGF-induced CGRP
expression in the DRG suggests that target of ERK path-
way may be a potential therapeutic strategies in treat-
ment of bladder pain with cystitis.
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